Company Participation - Jazz Pharmaceuticals will participate in the 2025 Wells Fargo Healthcare Conference with a fireside chat scheduled for September 3, 2025, at 6:30 a.m. PDT / 9:30 p.m. EDT / 2:30 p.m. IST [1] Webcast Information - An audio webcast of the fireside chat will be available on the Investors section of the Jazz Pharmaceuticals website, with a replay archived for 30 days [2] Company Overview - Jazz Pharmaceuticals is a global biopharma company focused on developing life-changing medicines for serious diseases, including sleep disorders, epilepsy, and cancer treatments [3] - The company is headquartered in Dublin, Ireland, and has a diverse portfolio of marketed medicines and a robust pipeline in oncology and neuroscience [3]

Core Insights - Jazz Pharmaceuticals plc will participate in the BofA Securities 2025 Healthcare Conference on May 14, 2025 [1] - An audio webcast of the fireside chat will be available on the company's investor website and archived for 30 days [2] Company Overview - Jazz Pharmaceuticals is a global biopharma company focused on developing life-changing medicines for serious diseases with limited therapeutic options [3] - The company has a diverse portfolio, including leading therapies for sleep disorders, epilepsy, and a growing range of cancer treatments [3] - Jazz is headquartered in Dublin, Ireland, with research and development facilities and manufacturing sites in multiple countries [3]